SPRIM GLOBAL INVESTMENTS IS ATTENDING THE
19th Clinical Trials Strategic Summit 2025
May 21-22, 2025
Munich Germany, NH München Ost Conference Center
Meet our Team
Join Julian Demmon, VP of Clinical Trial Financing at SPRIM Global Investments (TrialCap), and discover how SGI’s strategic investments and global reach can transform your clinical trial journey.
-
Learn how SGI can help accelerate your next clinical trial
-
Explore flexible investment strategies—equity, debt, and specialized vehicles
-
Tap into SGI’s global reach and expertise across R&D, CRO, and digital health
About Julian Demmon
Julian Demmon has over 30 years of experience designing, leading and executing trials across the drug development continuum. Julian was CEO of a UK AIM listed Biotech taking them from licensing, through proof of concept to first revenues and is based in Munich, Germany.
To schedule a meeting with Julian during the 19th Clinical Trials Strategic Summit 2025, please complete the form below.
